Results 1 to 10 of about 48,432 (237)

Emergence of Clinically Macrolide-Unresponsive Mycoplasma pneumoniae Segmental/Lobar Pneumonia and COVID-19 Pneumonia in Children in Taiwan, 2024–2025 [PDF]

Antibiotics
Background: To date, no study has compared the clinical characteristics of Mycoplasma pneumoniae-associated segmental/lobar pneumonia, Mycoplasma bronchopneumonia, and COVID-19 pneumonia primarily caused by the NB.1.8.1 variant in children.
Hao-Yuan Lee, Chien-Chin Chen, Shu-Hua Ko, Yu-Ling Huang, En-Pen Chang, Cheng-Yi Hsu, Jia Ru Wu, Wei-Hsin Chen, Yu-Chau Hsu, Meng-Yen Li, Yu-Lung Hsu, Wen-Yuan Lee, Chyi-Liang Chen   +12 more
doaj   +2 more sources

Taming the Inflammation: The Role of Corticosteroids in Pediatric Mycoplasma Pneumonia [PDF]

Children
Background/Objectives: To summarize the available evidence on the use of corticosteroids in the treatment of pediatric Mycoplasma pneumoniae pneumonia, including severe and refractory forms.
Maria Sole Valentino, Costanza Pagliani, Chiara Lovati, Roberta Caiazzo, Crescenzo Coppola, Raffaella Di Tonno, Marta Stracuzzi, Vania Giacomet   +7 more
doaj   +2 more sources

Prevalence of Genomic Resistance to Macrolide in Mycoplasma Isolates among Children with Community Acquired Pneumonia [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: Mycoplasma pneumonia is traditionally susceptible to macrolides, tetracycline and fluroquinolones. Since, tetracycline and fluoroquinolone are used cautiously in children, macrolides remain the antibiotic of choice for treating ...
Sivasambo Kalpana, Shanmugam Selvakumar, Velmurugan Lakshmi , Prabhu Dhandapani, Prem Suruliraj   +4 more
doaj   +1 more source

Cavitatory necrotising pneumonia with extrapulmonary multi-systemic involvement — a rare presentation of macrolide-resistant Mycoplasma pneumoniae

The Egyptian Journal of Internal Medicine, 2023
Background Mycoplasma pneumoniae is one of the leading causes of community-acquired pneumonia. Due to its microbiological variation, clinical presentations of mycoplasma infections are atypical and diverse.
Namitha Mohan, Vishal Dnyaneshwar Sawant, Alpana Kondekar   +2 more
doaj   +1 more source

Peripheral blood microR-146a and microR-29c expression in children with Mycoplasma pneumoniae pneumonia and its clinical value

Italian Journal of Pediatrics, 2023
Background We investigated changes in microR-29c and microR-146a expression in the serum of children with Mycoplasma pneumoniae pneumonia, analysed their relationship with inflammatory factors and disease severity, and evaluated their diagnostic ...
Jingcai Wang, Chunyan Guo, Lixin Yang, Peng Sun, Xiaoqing Jing   +4 more
doaj   +1 more source

A fulminant pneumonia due to Mycoplasma pneumoniae – Case report and literature review

IDCases, 2022
Fulminant pneumonia due to Mycoplasma pneumoniae [MP] is quite rare even though there is a high prevalence of Mycoplasma species infection in the general population.We report a case of an atypical pneumonia with Acute Respiratory Distress Syndrome (ARDS)
Athira Unni, MD, P.K. Hidayathulla, MD, K.P. Kavitha, MD, Mohammed Niyas Paloth, MD, Priyanka Raveendranadhan Nair, MD, Jayesh Kumar P, MD, Chandni Radhakrishnan, MD PhD   +6 more
doaj   +1 more source

Epidemiological features of community-acquired mycoplasma pneumonia

Фундаментальная и клиническая медицина, 2021
Aim. To analyse an epidemic process of community-acquired mycoplasma pneumonia in the Volga Federal District and the Nizhny Novgorod Region.Materials and Methods.
E. A. Koshkarina, O. A. Strazhnova, M. A. Sharabakina, O. M. Chekanina, V. V. Krasnov, P. G. Zubarov, O. V. Kovalishena   +6 more
doaj   +1 more source

Distribution difference of T lymphocyte subsets in common and refractory mycoplasma pneumonia and its impact on clinical treatment [PDF]

Jichu yixue yu linchuang
Objective To investigate the distribution difference of T lymphocyte subsets in common and refractory mycoplasma pneumonia and its impact on treatment. Methods Two hundred children with mycoplasma pneumonia hospitalized from October 2023 to January 2024 ...
ZHU Lin, FU Shuqin, JIA Wanyu, GUO Caili, SONG Chunlan
doaj   +1 more source

Acute saddle pulmonary embolism: A rare complication of mycoplasma pneumonia

Respiratory Medicine Case Reports, 2020
Background/Introduction: Mycoplasma pneumonia affects 1% of the population in the United States. The majority of patients infected with Mycoplasma experience upper respiratory tract infection symptoms, and about 10% of patients infected with Mycoplasma ...
Farrah Chilet, Arshad Muhammad Iqbal, Nikolay Mitzov, Abdulmagid Eddib, Salman Muddassir   +4 more
doaj   +1 more source

Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases [PDF]

, 2017
Respiratory tract disease can be associated with primary or secondary bacterial infections in dogs and cats and is a common reason for use and potential misuse, improper use, and overuse of antimicrobials.
Allen, Angus, Bannasch, Barrs, Beatty, Bennett, Berryessa, Bexfield, Binns, Bongrand, Boothe, Bradley, Burns, Chalker, Chalker, Chan, Chandler, Confalonieri, Danish Small Animal Veterinary Association (SvHKS), Dear, Demetriou, Demko, Dossin, Drawz, Egberink, Ellis, Erles, German, Guardabassi, Hartmann, Helps, Henderson, Hollis, Hunter, Jameson, Johnson, Johnson, Johnson, Johnson, Johnson, Keil, Kogan, Kompare, Lee, Lees, Levy, Lionel, Litster, MacPhail, Maggs, Martino, McInnis, McKiernan, Meijvis, Melendez, Meyers, Mochizuki, Morley, Mulholland, Murphy, Owen, Papich, Parnham, Peeters, Pesavento, Priestnall, Priestnall, Proulx, Pui-Ying, Quimby, Quimby, Radhakrishnan, Renshaw, Rheinwald, Rheinwald, Rooney, Rozanski, Ruch-Galle, Ruch-Gallie, Ruch-Gallie, Schulz, Schwarz, Sparkes, Speakman, Speakman, Spindel, Stillion, Sturgess, Sykes, Tart, Trow, Tynan, Vanderkooi, Veir, Velineni, Viitanen, Waddell, Walker, Welsh, Westfall, Wong, Zhu   +101 more
core   +4 more sources